N. Paul Ohori, MD
Professor of Pathology
Dr. Ohori is Medical Director of Cytopathology, UPMC Presbyterian.
Department of Pathology
200 Lothrop Street
Pittsburgh, PA 15213
Office Telephone: 412-647-9843
- BA - Johns Hopkins University, 1983
- MD - Medical College of Virginia, 1987
Clinical ExpertiseDr. Ohori is a Professor of Pathology in the Division of Anatomic Pathology and Medical Director of Cytopathology at UPMC Presbyterian. He has been a faculty member in the School of Medicine since 1992 and has been involved in medical student, cytotechnology student, resident, and fellow training. He has been the chair of the curriculum committee of the residency program in the Department of Pathology, Board Member of the School of Cytotechnology, and the cytopathology representative to the Molecular Anatomic Pathology Division. From 2001 to 2008, he served as the Director for the Cytopathology Fellowship Program.
Dr. Ohori has provided service to the UPMC system since 1992 and over the last 15 years, he has served as the Medical Director of Cytopathology at UPMC Presbyterian Hospital. His service responsibilities have focused on Non-Gynecologic Cytopathology and Thoracic Surgical Pathology. In this regard, he provides consultative expertise in thyroid, head and neck, pulmonary, and gastrointestinal cytopathology. Dr. Ohori participates in a number of regional and national conferences in the areas of thyroid cytopathology and thoracic pathology.
Dr. Ohori has focused his efforts in clinically related research in Non-gynecologic Cytopathology. In general, his research involves three main areas:
- Bridging the gap between cytopathology and surgical pathology by emphasizing correlation and understanding of organ specific concepts
- Applying ancillary technologies to refine diagnostic and pathogenetic information
- Quality improvement in cytopathology laboratory performance
Specifically, he has investigated the cytologic and molecular manifestations of thyroid, pancreaticobiliary and pulmonary neoplasms. Furthermore, he has been involved in improving cytopathology laboratory performance by developing a systematic method for cytologic-histologic correlation in non-gynecologic cytopathology.
SpecialtiesNon-gynecologic Cytopathology and Pulmonary Pathology
Selected PublicationsView Dr. Ohori's publications on PubMed
- Wharry LI, McCoy KL, Stang MT, Armstrong MJ, LeBeau SO, Tublin ME, Sholosh B, Silberman A, Ohori NP, Nikiforov YE, Hodak SP, Carty SE, Yip L. Large Thyroid Nodules (>e; 4 cm): Can Ultrasound and Cytology Reliably Exclude Cancer? World J Surg. 2014;38:614-21.
- Yip L, Wharry LI, Armstrong MJ, Silberman A, McCoy KL, Stang MT, Ohori NP, LeBeau SO, Coyne C, Nikiforova MN, Bauman JE, Johnson JT, Tublin ME, Hodak SP, Nikiforov YE, Carty SE. A Clinical Algorithm for Fine-Needle Aspiration Molecular Testing Effectively Guides the Appropriate Extent of Initial Thyroidectomy. Ann Surg. 2014;260:163-8.
- Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE. PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma. Thyroid. 2014;24:1369-74.
- Singhi AD, Nikiforova MN, Fasanella KE, McGrath KM, Pai RK, Ohori NP, Bartholow TL, Brand RE, Chennat JS, Lu X, Papachristou GI, Slivka A, Zeh HJ, Zureikat AH, Lee KK, Tsung A, Mantha GS, Khalid A. Preoperative GNAS and KRAS Testing in the Diagnosis of Pancreatic Mucinous Cysts. Clin Cancer Res. 2014;20:4381-9.
- Radkay LA, Chiosea SI, Seethala RR, Hodak SP, LeBeau SO, Yip L, McCoy KL, Carty SE, Schoedel KE, Nikiforova MN, Nikiforov YE, Ohori NP. Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics. Cancer Cytopathol. 2014;122:873-82.
- Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, Hodak SP, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer. 2014;120:3627-34.
- Schneider F, Smith M, Lane M, Pantanowitz L, Dacic S, Ohori NP. Adequacy of core needle biopsies and fine needle aspirates for molecular testing of lung adenocarcinomas. Am J Clin Pathol. 2015;143:193-200.